Axiom Investors’s Medtronic MDT Stock Holding History

Axiom Investors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-25,323	Closed	-$1.98M	–	146
2015 Q1	$1.98M	Buy	25,323 +4,800	+23%	+$364K	0.05%	113
2014 Q4	$1.48M	Buy	+20,523	New	+$1.43M	0.04%	128

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Axiom Investors's MDT Position: Q2 2015 in Review

Axiom Investors sold out of Medtronic (MDT) in Q2 2015, closing a stake of 25,323 shares — an estimated $1.98M sold.

Axiom Investors first reported a position in MDT in Q4 2014 and held it in 2 quarters. The position peaked at $1.98M in Q1 2015. 1,259 funds tracked by Wall St. Rank hold MDT as of Q2 2015.

Axiom Investors reported no remaining Medtronic position as of Q2 2015 after selling out during the quarter.
Axiom Investors sold 25,323 Medtronic shares in Q2 2015, an estimated $1.98M.
Axiom Investors first reported a position in Medtronic in Q4 2014 and held it in 2 quarters.
Axiom Investors's Medtronic position peaked at $1.98M in Q1 2015.
1,259 funds tracked by Wall St. Rank held Medtronic as of Q2 2015.

Based on Axiom Investors's 13F filing for Q2 2015, filed 13 Aug 2015.